Steroid use in acute liver failure
Top Cited Papers
Open Access
- 8 August 2013
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Hepatology
- Vol. 59 (2), 612-621
- https://doi.org/10.1002/hep.26678
Abstract
Drug-induced and indeterminate acute liver failure (ALF) might be due to an autoimmune-like hepatitis that is responsive to corticosteroid therapy. The aim of this study was to evaluate whether corticosteroids improve survival in fulminant autoimmune hepatitis, drug-induced, or indeterminate ALF, and whether this benefit varies according to the severity of illness. We conducted a retrospective analysis of autoimmune, indeterminate, and drug-induced ALF patients in the Acute Liver Failure Study Group from 1998-2007. The primary endpoints were overall and spontaneous survival (SS, survival without transplant). In all, 361 ALF patients were studied, 66 with autoimmune (25 steroids, 41 no steroids), 164 with indeterminate (21 steroids, 143 no steroids), and 131 with drug-induced (16 steroids, 115 no steroids) ALF. Steroid use was not associated with improved overall survival (61% versus 66%, P = 0.41), nor with improved survival in any diagnosis category. Steroid use was associated with diminished survival in certain subgroups of patients, including those with the highest quartile of the Model for Endstage Liver Disease (MELD) (>40, survival 30% versus 57%, P = 0.03). In multivariate analysis controlling for steroid use and diagnosis, age (odds ratio [OR] 1.37 per decade), coma grade (OR 2.02 grade 2, 2.65 grade 3, 5.29 grade 4), MELD (OR 1.07), and pH < 7.4 (OR 3.09) were significantly associated with mortality. Although steroid use was associated with a marginal benefit in SS overall (35% versus 23%, P = 0.047), this benefit did not persistent in multivariate analysis; mechanical ventilation (OR 0.24), MELD (OR 0.93), and alanine aminotransferase (1.02) were the only significant predictors of SS. Conclusion: Corticosteroids did not improve overall survival or SS in drug-induced, indeterminate, or autoimmune ALF and were associated with lower survival in patients with the highest MELD scores. (Hepatology 2014;59:612–621)This publication has 25 references indexed in Scilit:
- Drug-induced liver injuryCurrent Opinion in Gastroenterology, 2012
- Steroid and Ursodesoxycholic Acid Combination Therapy in Severe Drug-Induced Liver InjuryDigestion, 2011
- Autoimmune acute liver failure: Proposed clinical and histological criteriaHepatology, 2010
- Meloxicam as a Cause of Drug-Induced Autoimmune HepatitisDigestive Diseases and Sciences, 2009
- Corticosteroids or not in severe acute or fulminant autoimmune hepatitis: Therapeutic brinksmanship and the point beyond salvationLiver Transplantation, 2007
- AASLD position paper: The management of acute liver failureHepatology, 2005
- Minocycline as a Cause of Drug-Induced Autoimmune HepatitisAmerican Journal of Clinical Pathology, 2000
- The nature and prognostic implications of autoimmune hepatitis with an acute presentationJournal of Hepatology, 1994
- A double-blinded, randomized trial of hydrocortisone in acute hepatic failureDigestive Diseases and Sciences, 1991
- Randomised trial of steroid therapy in acute liver failure. Report from the European Association for the Study of the Liver (EASL).Gut, 1979